Page last updated: 2024-11-05

tipepidine and Depressive Disorder, Treatment-Resistant

tipepidine has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies

tipepidine: RN given refers to parent cpd

Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)

Research Excerpts

ExcerptRelevanceReference
"Tipepidine was given for 8 weeks as an augmentation."2.82Effects of add-on tipepidine on treatment-resistant depression: an open-label pilot trial. ( Hashimoto, K; Sato, K; Shirayama, Y; Suzuki, M; Takahashi, M, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shirayama, Y1
Suzuki, M1
Takahashi, M1
Sato, K1
Hashimoto, K1

Trials

1 trial available for tipepidine and Depressive Disorder, Treatment-Resistant

ArticleYear
Effects of add-on tipepidine on treatment-resistant depression: an open-label pilot trial.
    Acta neuropsychiatrica, 2016, Volume: 28, Issue:1

    Topics: Adult; Antidepressive Agents; Cognition; Dehydroepiandrosterone Sulfate; Depressive Disorder, Treatm

2016